D. Charnock-Jones

发表

Changes in Tumorigenesis- and Angiogenesis-related Gene Transcript Abundance Profiles in Ovarian Cancer Detected by Tailored High Density cDNA Arrays

Ann-Marie Martoglio, B. Tom, M. Starkey, 2000, Molecular medicine.

In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer

D. Charnock-Jones, Stephen K. Smith, S. Saidi, 2006, Molecular Cancer.

Morphological and molecular changes in the murine placenta exposed to normobaric hypoxia throughout pregnancy

D. Charnock-Jones, G. Burton, Hannah Matheson, 2015, The Journal of physiology.

The influence of the intrauterine environment on human placental development.

D. Charnock-Jones, E. Jauniaux, G. Burton, 2010, The International journal of developmental biology.

Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction.

D. Charnock-Jones, G. Burton, B. Hemmings, 2008, The American journal of pathology.

In-vivo gene transfer to the uterine endometrium.

D. Charnock-Jones, A. Sharkey, D. Jaggers, 1997, Human reproduction.

Vasohibin-1 is identified as a master-regulator of endothelial cell apoptosis using gene network analysis

S. Kuhara, D. Charnock-Jones, C. Print, 2013, BMC Genomics.

Bioinformatic analysis of primary endothelial cell gene array data illustrated by the analysis of transcriptome changes in endothelial cells exposed to VEGF-A and PlGF

B. Tom, D. Charnock-Jones, Stephen K. Smith, 2004, Angiogenesis.

Understanding endothelial cell apoptosis: what can the transcriptome, glycome and proteome reveal?

D. Charnock-Jones, C. Print, S. Miyano, 2007, Philosophical Transactions of the Royal Society B: Biological Sciences.

Gene network inference and visualization tools for biologists: application to new human transcriptome datasets

Benjamin E Dunmore, S. Kuhara, D. Charnock-Jones, 2011, Nucleic acids research.

Independent component analysis of microarray data in the study of endometrial cancer

David P. Kreil, D. Charnock-Jones, Stephen K. Smith, 2004, Oncogene.

MMP1 bimodal expression and differential response to inflammatory mediators is linked to promoter polymorphisms

D. Charnock-Jones, C. Print, Nicola A Johnson, 2011, BMC Genomics.

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

Till Acker, Ulf Eriksson, Ingeborg Stalmans, 2001, Nature Medicine.

The pregnancy outcome prediction (POP) study: Investigating the relationship between serial prenatal ultrasonography, biomarkers, placental phenotype and adverse pregnancy outcomes

D. Charnock-Jones, U. Sovio, Gordon C. S. Smith, 2017, Placenta.

Hepatocyte growth factor levels during normal and intra-uterine growth-restricted pregnancies.

D. Charnock-Jones, S. Smith, D. Clark, 1998, Placenta.

Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity.

D. Charnock-Jones, S. Smith, K. Day, 1999, Molecular endocrinology.

Nuclear factor-kappa B, p38, and stress-activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress: effects of antioxidant vitamins.

D. Charnock-Jones, E. Jauniaux, G. Burton, 2007, The American journal of pathology.

Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium.

D. Charnock-Jones, D. Baird, A. Sharkey, 2007, Molecular human reproduction.

Generation and use of a tailored gene array to investigate vascular biology

D. Charnock-Jones, Stephen K. Smith, C. Print, 2004, Angiogenesis.

Intralobular differences in antioxidant enzyme expression and activity reflect the pattern of maternal arterial bloodflow within the human placenta.

D. Charnock-Jones, E. Jauniaux, G. Burton, 2003, Placenta.

Developmental control of the Nlrp6 inflammasome and a substrate, IL-18, in mammalian intestine.

D. Charnock-Jones, A. Fowden, G. Belteki, 2011, American journal of physiology. Gastrointestinal and liver physiology.

Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis.

D. Charnock-Jones, A. Prentice, R. Butt, 2005, Human reproduction.

Vascular development is disrupted by endothelial cell-specific expression of the anti-apoptotic protein Bcl-2

D. Charnock-Jones, Stephen K. Smith, C. Print, 2006, Angiogenesis.

Expression of mRNA for vascular endothelial growth factor in human placenta.

D. Charnock-Jones, Stephen K. Smith, A. Sharkey, 1993, Journal of reproduction and fertility.

Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry.

D. Charnock-Jones, A. Sharkey, S. Smith, 1995, Journal of reproduction and fertility.

Expression of CD105 (endoglin) in arteriolar endothelial cells of human endometrium throughout the menstrual cycle.

D. Charnock-Jones, S. Smith, E. Zhang, 2002, Reproduction.

Expression of gastrin‐releasing peptide is increased by prolonged stretch of human myometrium, and antagonists of its receptor inhibit contractility

D. Charnock-Jones, Y. Cordeaux, Gordon C.S. Smith, 2012, The Journal of physiology.

Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time.

D. Charnock-Jones, Stephen K. Smith, A. Sharkey, 1994, Journal of reproduction and fertility.

VEGF-A loss in the haematopoietic and endothelial lineages exacerbates age-induced renal changes.

D. Charnock-Jones, Stephen K. Smith, C. Print, 2010, Microvascular research.

The Effect of an Oxytocin Receptor Antagonist (Retosiban, GSK221149A) on the Response of Human Myometrial Explants to Prolonged Mechanical Stretch.

D. Charnock-Jones, Y. Cordeaux, Gordon C.S. Smith, 2015, Endocrinology.

Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction.

D. Charnock-Jones, S. Smith, M. L. Harrison-Woolrych, 1994, The Journal of clinical endocrinology and metabolism.

Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium.

D. Charnock-Jones, A. Sharkey, S. Smith, 1997, Human reproduction.

Menstrual effluent in endometriosis shows no difference in volume, VEGF-A, MMP2 and MMP9 or sFLT.

D. Charnock-Jones, Stephen K. Smith, K. Day, 2006, Reproductive biomedicine online.

Antiangiogenic Agents Are Effective Inhibitors of Endometriosis

K. Osteen, B. Tom, D. Charnock-Jones, 2003 .

Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis.

D. Charnock-Jones, Stephen K. Smith, A. Prentice, 1996, Human reproduction.

Slowing of fetal growth and elevated maternal serum sFLT1:PlGF are associated with early term spontaneous labor

D. Charnock-Jones, U. Sovio, Gordon C. S. Smith, 2021, American journal of obstetrics and gynecology.

Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study.

D. Charnock-Jones, U. Sovio, Gordon C. S. Smith, 2018, The Lancet. Child & adolescent health.

Progestin regulates chemokine (C-X-C motif) ligand 14 transcript level in human endometrium.

D. Charnock-Jones, Stephen K. Smith, N. Mokhtar, 2010, Molecular human reproduction.

Transcript profile and localization of Wnt signaling-related molecules in human endometrium.

D. Charnock-Jones, Stephen K. Smith, Ching-wen Cheng, 2008, Fertility and sterility.

Decreased levels of the potent regulator of monocyte/macrophage activation, interleukin-13, in the peritoneal fluid of patients with endometriosis.

D. Charnock-Jones, A. Prentice, S. Smith, 1997, Human reproduction.

Endoplasmic reticulum stress disrupts placental morphogenesis: implications for human intrauterine growth restriction

D. Charnock-Jones, C. Senner, G. Burton, 2012, The Journal of pathology.

The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo

D. Charnock-Jones, Kelvin Chan, L. Morbidelli, 2011, Angiogenesis.

vavCre Transgenic mice: A tool for mutagenesis in hematopoietic and endothelial lineages

D. Charnock-Jones, Stephen K. Smith, C. Print, 2002, Genesis.

Placental endoplasmic reticulum stress negatively regulates transcription of placental growth factor via ATF4 and ATF6β: implications for the pathophysiology of human pregnancy complications

D. Charnock-Jones, G. Burton, H. Yung, 2016, The Journal of pathology.

Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells.

D. Charnock-Jones, Stephen K. Smith, R. Plevin, 1994, Biology of reproduction.

Characterization and expression of vascular endothelial growth factor (VEGF) in the ovine corpus luteum.

D. Charnock-Jones, S. Smith, R. Moor, 1996, Journal of reproduction and fertility.

Soluble vascular endothelial growth factor receptor 1 inhibits edema and epithelial proliferation induced by 17beta-estradiol in the mouse uterus.

D. Charnock-Jones, Stephen K. Smith, G. Burton, 2003, Endocrinology.

Wnt-1 signaling inhibits human umbilical vein endothelial cell proliferation and alters cell morphology.

D. Charnock-Jones, Stephen K. Smith, Ching-wen Cheng, 2003, Experimental cell research.

Placental vessel adaptation during gestation and to high altitude: changes in diameter and perivascular cell coverage.

D. Charnock-Jones, G. Burton, S. Smith, 2002, Placenta.

Placental Vascular Morphogenesis: Introduction and Overview

D. Charnock-Jones, Stephen K. Smith, 2001 .

Placental vascular morphogenesis.

D. Charnock-Jones, G. Burton, 2000, Bailliere's best practice & research. Clinical obstetrics & gynaecology.

Angiogenesis and Vascular Endothelial Growth Factor (VEGF) in Reproduction

D. Charnock-Jones, Stephen K. Smith, Yulong He, 2002 .

Differential activation of placental unfolded protein response pathways implies heterogeneity in causation of early- and late-onset pre-eclampsia

D. Charnock-Jones, G. Burton, H. Yung, 2014, The Journal of pathology.

Human placenta has no microbiome but can harbour potential pathogens

D. Charnock-Jones, M. D. de Goffau, U. Sovio, 2019, Nature.

Developmental Expression and Glucocorticoid Control of the Leptin Receptor in Fetal Ovine Lung

D. Charnock-Jones, A. Fowden, M. D. De Blasio, 2015, PloS one.

Vascular endothelial growth factor and corpus luteum angiogenesis

D. Charnock-Jones, Stephen K. Smith, 1998, Angiogenesis.

Distribution of vascular endothelial growth factor (VEGF) and its binding sites at the maternal-fetal interface during gestation in pigs.

D. Charnock-Jones, S. Smith, K. Day, 2001, Reproduction.

Immunolocalization of the apoptosis regulating proteins Bcl-2 and Bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis.

D. Charnock-Jones, Stephen K. Smith, A. Prentice, 1997, Human reproduction.

Novel antiangiogenic agents for use in contraception.

D. Charnock-Jones, Stephen K. Smith, A. Sharkey, 2005, Contraception.

Cloning, expression and genomic organization of human placental protein disulfide isomerase (previously identified as phospholipase C alpha).

D. Charnock-Jones, S. Smith, K. Day, 1996, The international journal of biochemistry & cell biology.

Birth weight to placenta weight ratio and its relationship to ultrasonic measurements, maternal and neonatal morbidity: A prospective cohort study of nulliparous women.

D. Charnock-Jones, U. Sovio, S. Scherjon, 2017, Placenta.

Secretion of Tumor Necrosis Factor-α from Human Placental Tissues Induced by Hypoxia-Reoxygenation Causes Endothelial Cell Activation in Vitro

D. Charnock-Jones, G. Burton, J. Skepper, 2004 .

A Maternal Serum Metabolite Ratio Predicts Large for Gestational Age Infants at Term: A Prospective Cohort Study

D. Charnock-Jones, U. Sovio, D. Lawlor, 2021, The Journal of clinical endocrinology and metabolism.

A maternal serum metabolite ratio predicts fetal growth restriction at term

D. Lawlor, D. Charnock-Jones, U. Sovio, 2020, Nature Medicine.

Endoplasmic reticulum stress exacerbates ischemia‐reperfusion‐induced apoptosis through attenuation of Akt protein synthesis in human choriocarcinoma cells

D. Charnock-Jones, G. Burton, A. Tolkovsky, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Placental Endoplasmic Reticulum Stress and Oxidative Stress in the Pathophysiology of Unexplained Intrauterine Growth Restriction and Early Onset Preeclampsia

D. Charnock-Jones, G. Burton, H. Yung, 2009, Placenta.

Role of soluble endoglin in BMP9 signaling

D. Charnock-Jones, N. Morrell, P. ten Dijke, 2019, Proceedings of the National Academy of Sciences.

A longitudinal study of biochemical variables in women at risk of preeclampsia.

L. Poston, D. Charnock-Jones, F. Kelly, 2002, American journal of obstetrics and gynecology.

Human pregnancy zone protein stabilizes misfolded proteins including preeclampsia- and Alzheimer’s-associated amyloid beta peptide

C. Dobson, D. Charnock-Jones, M. Ranson, 2019, Proceedings of the National Academy of Sciences.

Human zone protein stabilises misfolded proteins including preeclampsia- and Alzheimer’s-associated amyloid beta peptide

C. Dobson, D. Charnock-Jones, M. Ranson, 2019 .

Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma.

D. Charnock-Jones, Stephen K. Smith, C. Holland, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Expression of Vascular Endothelial Growth Factor ( VEGF )-D and Its Receptor , VEGF Receptor 3 , as a Prognostic Factor in Endometrial Carcinoma 1

D. Charnock-Jones, Stephen K. Smith, C. Holland, 2003 .

Evolutionary History of Endogenous Human Herpesvirus 6 Reflects Human Migration out of Africa

D. Charnock-Jones, N. Parrish, J. Breuer, 2020, Molecular biology and evolution.

Analysis of PPARα-dependent and PPARα-independent transcript regulation following fenofibrate treatment of human endothelial cells

Masao Nagasaki, Atsushi Doi, Satoru Miyano, 2009, Angiogenesis.

Leptin Matures Aspects of Lung Structure and Function in the Ovine Fetus

D. Charnock-Jones, A. Fowden, M. D. De Blasio, 2015, Endocrinology.

The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium.

D. Charnock-Jones, Stephen K. Smith, A. Sharkey, 2000, Human reproduction.

Cyclooxygenase-1 and -2 in human placenta and placental bed after normal and pre-eclamptic pregnancies.

D. Charnock-Jones, Stephen K. Smith, S. Smith, 1997, Human reproduction.

Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling

D. Charnock-Jones, G. Burton, D. Sanders, 2010, Cardiovascular research.

Original research article Novel antiangiogenic agents for use in contraception

D. Charnock-Jones, Stephen K. Smith, A. Sharkey, 2005 .

A Vascular Endothelial Growth Factor Antagonist Is Produced by the Human Placenta and Released into the Maternal Circulation1

A. N. Corps, D. Charnock-Jones, Stephen K. Smith, 1998 .

Expression of CD105 (endoglin) in arteriolar endothelial cells of human endometrium throughout the menstrual cycle.

D. Charnock-Jones, S. Smith, E. G. Zhang, 2002, Reproduction.

A Lower Maternal Cortisol-to-Cortisone Ratio Precedes Clinical Diagnosis of Preterm and Term Preeclampsia by Many Weeks

D. Charnock-Jones, U. Sovio, Gordon C. S. Smith, 2019, The Journal of clinical endocrinology and metabolism.

Working with oxygen and oxidative stress in vitro.

D. Charnock-Jones, E. Jauniaux, G. Burton, 2006, Methods in molecular medicine.

Linear amplification sequencing with dye terminators.

D. Charnock-Jones, A. Rosenthal, 1993, Methods in molecular biology.

Impact of Metformin Treatment on Human Placental Energy Production and Oxidative Stress

D. Charnock-Jones, C. Aiken, S. Ozanne, 2022, Frontiers in Cell and Developmental Biology.

Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy.

D. Charnock-Jones, Stephen K. Smith, A. Sharkey, 1996, Human reproduction.

Characterization of Serotonin Receptors in Pregnant Human Myometrium

D. Charnock-Jones, D. Pasupathy, Y. Cordeaux, 2009, Journal of Pharmacology and Experimental Therapeutics.

Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia

D. Charnock-Jones, S. Charnock-Jones, 2016, Journal of reproductive immunology.

MMP1 bimodal expression and differential response to inflammatory mediators is linked to promoter polymorphisms

D. Charnock-Jones, C. Print, M. Affara, 2011, BMC Genomics.

Influence of speed of sample processing on placental energetics and signalling pathways: Implications for tissue collection☆

D. Charnock-Jones, G. Burton, A. Murray, 2014, Placenta.

Inhibition of Stat3 activation in the endometrium prevents implantation: a nonsteroidal approach to contraception.

D. Charnock-Jones, Stephen K. Smith, E. Campbell, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Expression and Localization of the Th2‐type Cytokine Interleukin‐13 and Its Receptor in the Placenta During Human Pregnancy

D. Charnock-Jones, Stephen K. Smith, A. Sharkey, 1998, American journal of reproductive immunology.

Abnormal placental CD8+ T‐cell infiltration is a feature of fetal growth restriction and pre‐eclampsia

D. Charnock-Jones, U. Sovio, N. Sebire, 2020, The Journal of physiology.

Isolation of macrophages (Hofbauer cells) from human term placenta and their prostaglandin E2 and thromboxane production.

D. Charnock-Jones, S. Smith, H. Zahradnik, 1997, Human reproduction.

The Role of Leukaemia Inhibitory Factor and Interleukin-6 in Human Reproduction

D. Charnock-Jones, A. Sharkey, S. Smith, 2022 .

The human placenta exhibits a unique transcriptomic void

D. Charnock-Jones, A. Lawson, Luke M. R. Harvey, 2022, bioRxiv.

Reply: Is the dose to inhibit the COX-2 enzyme in nude mice also adequate in human endometrial tissues?

D. Charnock-Jones, M. L. Hull, 2005 .

Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre‐eclampsia

D. Charnock-Jones, A. Sharkey, S. Smith, 1996, European journal of clinical investigation.

Localization of leukemia inhibitory factor and its receptor in human placenta throughout pregnancy.

D. Charnock-Jones, Stephen K. Smith, A. Sharkey, 1999, Biology of reproduction.

The Effect of Delaying Childbirth on Primary Cesarean Section Rates

J. Pell, I. White, D. Charnock-Jones, 2008, PLoS medicine.

Increased Placental sFLT1 (Soluble fms-Like Tyrosine Kinase Receptor-1) Drives the Antiangiogenic Profile of Maternal Serum Preceding Preeclampsia but Not Fetal Growth Restriction

D. Charnock-Jones, U. Sovio, F. Gaccioli, 2022, Hypertension.

Placental polyamines regulate acetyl-coA and histone acetylation in a sex-specific manner

D. Charnock-Jones, Gordon C. S. Smith, A. Murray, 2021, bioRxiv.

The RNA landscape of the human placenta in health and disease

Paul D. W. Kirk, S. Richardson, D. Charnock-Jones, 2021, Nature communications.

Inherent mosaicism and extensive mutation of human placentas

Matthew D. Young, P. Campbell, D. Charnock-Jones, 2021, Nature.

Somatic mutations reveal widespread mosaicism and mutagenesis in human placentas

Matthew D. Young, P. Campbell, D. Charnock-Jones, 2021, bioRxiv.

Fetal inheritance of chromosomally integrated human herpesvirus 6 predisposes the mother to pre-eclampsia

D. Charnock-Jones, M. D. de Goffau, U. Sovio, 2020, Nature Microbiology.

The association between first trimester AFP to PAPP-A ratio and placentally-related adverse pregnancy outcome.

D. Charnock-Jones, U. Sovio, Gordon C. S. Smith, 2019, Placenta.

4-Hydroxyglutamate is a novel predictor of pre-eclampsia

Katya L. Masconi, D. Lawlor, A. Wood, 2019, International journal of epidemiology.

Detecting eukaryotic microbiota with single-cell sensitivity in human tissue

D. Charnock-Jones, M. D. de Goffau, U. Sovio, 2018, Microbiome.

Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia

A. Wood, D. Charnock-Jones, U. Sovio, 2018, JCI insight.

Genome-wide oxidative bisulfite sequencing identifies sex-specific methylation differences in the human placenta

D. Charnock-Jones, U. Sovio, Sungsam Gong, 2018, Epigenetics.

Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers.

D. Charnock-Jones, U. Sovio, Gordon C. S. Smith, 2017, American journal of obstetrics and gynecology.

Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor Ratio

D. Charnock-Jones, U. Sovio, M. Hund, 2017, Hypertension.

The relationship between human placental morphometry and ultrasonic measurements of utero-placental blood flow and fetal growth.

D. Charnock-Jones, U. Sovio, G. C. Smith, 2016, Placenta.

Study protocol. A prospective cohort study of unselected primiparous women: the pregnancy outcome prediction study

I. White, D. Charnock-Jones, Gordon C. S. Smith, 2008, BMC pregnancy and childbirth.

Stimulation of Contractions in Human Myometrium by Serotonin is Unmasked by Smooth Muscle Relaxants

D. Charnock-Jones, Y. Cordeaux, Gordon C.S. Smith, 2008, Reproductive Sciences.

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

D. Charnock-Jones, Stephen K. Smith, P. Barker, 1995, Journal of the National Cancer Institute.

Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines.

D. Charnock-Jones, Stephen K. Smith, A. Sharkey, 1993, Biology of reproduction.

categoriesexpression reprogramming in key gene function Microarray analysis of trophoblast differentiation

D. Charnock-Jones, Stephen K. Smith, B. Aronow, 2015 .

The Regulation and Localization of Angiopoietin-1, -2, and Their Receptor Tie2 in Normal and Pathologic Human Placentae

D. Charnock-Jones, Stephen K. Smith, P. Baker, 2001, Molecular medicine.

RNA-Seq reveals changes in human placental metabolism, transport and endocrinology across the first–second trimester transition

D. Charnock-Jones, P. Robson, E. Jauniaux, 2021, Biology open.

Human Early Placental Development: Potential Roles of the Endometrial Glands

D. Charnock-Jones, E. Jauniaux, G. Burton, 2007, Placenta.

Expression of prostacyclin and thromboxane synthases in placenta and placental bed after pre-eclamptic pregnancies.

D. Charnock-Jones, S. Smith, B. Viville, 1996, Placenta.

Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation.

T M Mayhew, P Kaufmann, D. Charnock-Jones, 2004, Placenta.

Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction.

D. Charnock-Jones, A. Prentice, E. Thomas, 1993, Human reproduction.

Perturbation of placental protein glycosylation by endoplasmic reticulum stress promotes maladaptation of maternal hepatic glucose metabolism

D. Charnock-Jones, G. Burton, A. Dell, 2022, iScience.

Determination of the transcript profile of human endometrium.

B. Tom, D. Charnock-Jones, Stephen K. Smith, 2003, Molecular human reproduction.

Determination of the transcript proﬁle of human endometrium

B. Tom, D. Charnock-Jones, Stephen K. Smith, 2002 .

Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia.

D. Charnock-Jones, G. Burton, J. Skepper, 2004, The American journal of pathology.

Hypoxia-Reoxygenation: A Potent Inducer of Apoptotic Changes in the Human Placenta and Possible Etiological Factor in Preeclampsia

D. Charnock-Jones, G. Burton, J. Skepper, 2002, Circulation research.

Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma.

D. Charnock-Jones, Stephen K. Smith, T. Kawarabayashi, 2004, Gynecologic oncology.

Expression of vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in conceptus and endometrium during implantation in the rhesus monkey.

D. Charnock-Jones, D. Ghosh, J. Sengupta, 2000, Molecular human reproduction.

Oxidative stress, gene expression, and protein changes induced in the human placenta during labor.

D. Charnock-Jones, E. Jauniaux, G. Burton, 2007, The American journal of pathology.

Activation of mutated K‐ras in donor endometrial epithelium and stroma promotes lesion growth in an intact immunocompetent murine model of endometriosis

D. Charnock-Jones, Stephen K. Smith, C. Print, 2011, The Journal of pathology.

Effect of low-dose mifepristone administration on day 2 after ovulation on transcript profiles in implantation-stage endometrium of rhesus monkeys.

D. Charnock-Jones, D. Ghosh, J. Sengupta, 2009, Reproduction.

Endometrial-peritoneal interactions during endometriotic lesion establishment.

S. Tavaré, D. Charnock-Jones, Stephen K. Smith, 2008, The American journal of pathology.

Extension of incomplete cDNAs (ESTs) by biotin/streptavidin-mediated walking using the polymerase chain reaction.

D. Charnock-Jones, A. Rosenthal, M. Platzer, 1994, Journal of biotechnology.

D. Charnock-Jones, Stephen K. Smith, J. Bowen, 2022 .

RNA-seq reveals conservation of function among the yolk sacs of human, mouse, and chicken

D. Charnock-Jones, Sungsam Gong, E. Jauniaux, 2017, Proceedings of the National Academy of Sciences.

Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.

D. Charnock-Jones, A. Prentice, A. Sharkey, 1996, The Journal of clinical investigation.

Redefining preeclampsia using placenta-derived biomarkers.

D. Charnock-Jones, C. Redman, J. Roberts, 2013, Hypertension.

Three-dimensional morphological analysis of placental terminal villi

D. Charnock-Jones, G. Burton, G. Marom, 2019, Interface Focus.

Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies.

T M Mayhew, P Kaufmann, D. Charnock-Jones, 2004, Placenta.

Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy.

T M Mayhew, P Kaufmann, D. Charnock-Jones, 2004, Placenta.

The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Vascular Endothelial Growth Factor Expression in Human Endometrium Is Regulated by Hypoxia*

D. Charnock-Jones, Stephen K. Smith, A. Sharkey, 2022 .

IFPA meeting 2018 workshop report II: Abnormally invasive placenta; inflammation and infection; preeclampsia; gestational trophoblastic disease and drug delivery.

D. Charnock-Jones, S. Saito, C. Redman, 2019, Placenta.

Placental angiogenesis: the role of the VEGF family of proteins

D. Charnock-Jones, D. Clark, Clark De, 2004, Angiogenesis.

Vasohibin-1 is identified as a master-regulator of endothelial cell apoptosis using gene network analysis

S. Kuhara, D. Charnock-Jones, C. Print, 2013, BMC Genomics.

Hepatocyte growth factor/scatter factor and its receptor c-met: localisation and expression in the human placenta throughout pregnancy.

D. Charnock-Jones, H. Sowter, A. Sharkey, 1996, The Journal of endocrinology.

A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation.

A. N. Corps, D. Charnock-Jones, S. Smith, 1998, Biology of reproduction.

Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation.

D. Charnock-Jones, S. Smith, A. Evans, 1998, The Journal of endocrinology.

Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor.

T. E. Fitzpatrick, D. Charnock-Jones, S. Macdonald-Goodfellow, 2003, Experimental cell research.

Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata.

D. Charnock-Jones, A. Sharkey, S. Smith, 1995, The Journal of clinical endocrinology and metabolism.

Fetal inheritance of chromosomally integrated HHV-6 predisposes to preeclampsia in the mother

D. Charnock-Jones, M. D. de Goffau, U. Sovio, 2020, Nature microbiology.

Placental energy metabolism in health and disease - significance of development and implications for preeclampsia.

D. Charnock-Jones, C. Aiken, Gordon C. S. Smith, 2020, American journal of obstetrics and gynecology.

Transcriptome analysis of endometrial cancer identifies peroxisome proliferator-activated receptors as potential therapeutic targets.

D. Charnock-Jones, Stephen K. Smith, C. Print, 2004, Molecular cancer therapeutics.

The effect of RU486 on the gene expression profile in an endometrial explant model.

A Prentice, D. Charnock-Jones, C. Print, 2003, Molecular human reproduction.

Energy status and HIF signalling in chorionic villi show no evidence of hypoxic stress during human early placental development

D. Charnock-Jones, E. Jauniaux, G. Burton, 2014, Molecular human reproduction.

New protocols for DNA sequencing with dye terminators.

D. Charnock-Jones, A. Rosenthal, D S Charnock-Jones, 1992, DNA sequence : the journal of DNA sequencing and mapping.

Antiangiogenic agents are effective inhibitors of endometriosis.

K. Osteen, B. Tom, D. Charnock-Jones, 2003, The Journal of clinical endocrinology and metabolism.

Regulation of vascular growth and function in the human placenta.

D. Charnock-Jones, E. Jauniaux, G. Burton, 2009, Reproduction.

Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration.

D. Charnock-Jones, Stephen K. Smith, T. Fan, 2008, Biochemical and biophysical research communications.

The Placental Circulations

D. Charnock-Jones, E. Jauniaux, G. Burton, 2021, Benirschke's Pathology of the Human Placenta.

Capture PCR: An Efficient Method for Walking Along Chromosomal DNA and cDNA

D. Charnock-Jones, A. Rosenthal, M. Platzer, 1994 .

Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-alpha in menstrual endometrium and effluent in women with menorrhagia.

D. Charnock-Jones, Stephen K. Smith, K. Day, 2006, Human reproduction.

Vascular development in embryoid bodies: quantification of transgenic intervention and antiangiogenic treatment

D. Charnock-Jones, Stephen K. Smith, C. Print, 2007, Angiogenesis.

Immunoneutralization of vascular endothelial growth factor inhibits pregnancy establishment in the rhesus monkey (Macaca mulatta).

D. Charnock-Jones, D. Ghosh, J. Sengupta, 2007, Reproduction.

Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma

D. Charnock-Jones, Stephen K. Smith, C. Holland, 2003, British Journal of Cancer.

Soluble flt‐1 and the angiopoietins in the development and regulation of placental vasculature *

D. Charnock-Jones, 2002, Journal of anatomy.

Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function.

L. Poston, D. Charnock-Jones, F. Kelly, 2002, American journal of obstetrics and gynecology.

Recognizing the reagent microbiome

Julian Parkhill, Josef Wagner, Sharon J. Peacock, 2018, Nature Microbiology.

Is estradiol cardioprotection a nitric oxide-mediated effect?

J. Connell, A. Dominiczak, D. Charnock-Jones, 2002, Human reproduction.

VEGF mRNA levels in placentae from pregnancies complicated by pre‐eclampsia

D. Charnock-Jones, Stephen K. Smith, A. Sharkey, 1996, British journal of obstetrics and gynaecology.

Three-dimensional modeling of human placental terminal villi.

D. Charnock-Jones, G. Burton, M. Oyen, 2016, Placenta.

Regulation of AKT Phosphorylation at Ser473 and Thr308 by Endoplasmic Reticulum Stress Modulates Substrate Specificity in a Severity Dependent Manner

D. Charnock-Jones, G. Burton, H. Yung, 2011, PloS one.

Author Correction: Human placenta has no microbiome but can contain potential pathogens

D. Charnock-Jones, M. D. de Goffau, U. Sovio, 2019, Nature.

Fetal inheritance of chromosomally integrated human herpesvirus 6 predisposes the mother to pre-eclampsia

D. Charnock-Jones, M. D. de Goffau, U. Sovio, 2020, Nature Microbiology.

A high-throughput platform for detailed lipidomic analysis of a range of mouse and human tissues

D. Charnock-Jones, Gordon C. S. Smith, S. Ozanne, 2020, Analytical and Bioanalytical Chemistry.

Effects of medroxyprogesterone acetate on gene expression in myometrial explants from pregnant women.

D. Charnock-Jones, J. Romijn, H. Middelkoop, 2010, The Journal of clinical endocrinology and metabolism.

Messenger RNA encoding thiol protein disulphide isomerase in amnion, chorion and placenta in human term and preterm labour

D. Charnock-Jones, Stephen K. Smith, J. Morrison, 1996, British journal of obstetrics and gynaecology.

The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium.

D. Charnock-Jones, S. Smith, D. Archer, 1999, Human reproduction.

Changes in Gene Expression during Wolffian Duct Development

D. Charnock-Jones, C. Print, I. Hughes, 2006, Hormone Research in Paediatrics.

Group B Streptococcus and the risk of perinatal morbidity and mortality following term labor.

D. Charnock-Jones, K. Stephens, Gordon C. S. Smith, 2023, American journal of obstetrics and gynecology.

ELABELA/APELA Levels Are Not Decreased in the Maternal Circulation or Placenta among Women with Preeclampsia

D. Charnock-Jones, Sungsam Gong, Gordon C. S. Smith, 2018, The American journal of pathology.

Recognizing the reagent microbiome

D. Charnock-Jones, J. Parkhill, Gordon C. S. Smith, 2018, Nature Microbiology.

Disruption of paraoxonase 3 impairs proliferation and antioxidant defenses in human A549 cells and causes embryonic lethality in mice.

D. Charnock-Jones, G. Belteki, D. Licence, 2012, American journal of physiology. Endocrinology and metabolism.

Paraoxonase-3, a putative circulating antioxidant, is systemically up-regulated in late gestation in the fetal rat, sheep, and human.

A. Curley, D. Charnock-Jones, A. Fowden, 2010, The Journal of clinical endocrinology and metabolism.

Intralobular differences in antioxidant enzyme: expression and activity reflect oxygen gradients within the human placenta

D. Charnock-Jones, E. Jauniaux, G. Burton, 2003 .

Single-Cell Analysis Identifies Thymic Maturation Delay in Growth-Restricted Neonatal Mice

D. Charnock-Jones, C. Abell, Ziyi Yu, 2018, bioRxiv.

Computational modeling of the structure-function relationship in human placental terminal villi.

D. Charnock-Jones, G. Burton, J. Olsthoorn, 2016, Journal of biomechanics.

Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle.

D. Charnock-Jones, I. Cameron, A. Davenport, 1992, The Journal of clinical endocrinology and metabolism.

Batch effects account for the main findings of an in utero human intestinal bacterial colonization study

D. Charnock-Jones, M. D. de Goffau, J. Parkhill, 2021, Microbiome.

Human placenta has no microbiome but can contain potential pathogens

D. Charnock-Jones, M. D. de Goffau, U. Sovio, 2019, Nature.

VEGF-A and Serum Withdrawal Induced Changes in the Transcript Profile in Human Endometrial Endothelial Cells

D. Charnock-Jones, M. Olovsson, R. Catalano, 2010, Reproductive sciences.

Author Correction: Human placenta has no microbiome but can contain potential pathogens

D. Charnock-Jones, U. Sovio, J. Parkhill, 2019, Nature.

Quantitative Cellular and Molecular Analysis of the Effect of Progesterone Withdrawal in a Murine Model of Decidualization1

D. Charnock-Jones, Stephen K. Smith, C. Print, 2007, Biology of reproduction.

Angiogenic growth factor expression in placenta.

D. Charnock-Jones, S. Smith, D. Clark, 2000, Seminars in perinatology.

Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors.

A. N. Corps, D. Charnock-Jones, H. Sowter, 1997, Laboratory investigation; a journal of technical methods and pathology.

Retosiban Prevents Stretch-Induced Human Myometrial Contractility and Delays Labor in Cynomolgus Monkeys

D. Charnock-Jones, I. Aye, D. Stanislaus, 2017, The Journal of clinical endocrinology and metabolism.

The role of leukaemia inhibitory factor and interleukin-6 in human reproduction

D. Charnock-Jones, Stephen K. Smith, A. M. Sharkey, 1998 .

Focus on Vascular Function in Female Reproduction Regulation of vascular growth and function in the human placenta

D. Charnock-Jones, G. Burton, E. Jauniaux, 2009 .

Effect of low-dose mifepristone administration on day 2 after ovulation on transcript profiles in implantation-stage endometrium of rhesus monkeys.

D. Charnock-Jones, D. Ghosh, J. Sengupta, 2009, Reproduction.

In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer

D. Charnock-Jones, S. Saidi, Stephen K. Smith, 2006, Molecular Cancer.

Changes in Tumorigenesis- and Angiogenesis-related Gene Transcript Abundance Profiles in Ovarian Cancer Detected by Tailored High Density cDNA Arrays

Ann-Marie Martoglio, D. Charnock-Jones, Brian D. M. Tom, 2000, Molecular medicine.